hacked by p@3t_b@y for turks

August 21, 2009

Oecologia - Altitudinal patterns of tick and host abundance: a potential role for climate change in regulating tick-borne diseases?

Lucy Gilbert

Macaulay Land Use Research Institute, Craigiebuckler, Aberdeen, AB31 8QH, UK

Received: 15 April 2009  Accepted: 24 July 2009  Published online: 15 August 2009

Communicated by R. Brandl.
Abstract  The impact of climate change on vector-borne infectious diseases is currently controversial. In Europe the primary arthropod vectors of zoonotic diseases are ticks, which transmit Borrelia burgdorferi sensu lato (the agent of Lyme disease), tick-borne encephalitis virus and louping ill virus between humans, livestock and wildlife. Ixodes ricinus ticks and reported tick-borne disease cases are currently increasing in the UK. Theories for this include climate change and increasing host abundance. This study aimed to test how I. ricinus tick abundance might be influenced by climate change in Scotland by using altitudinal gradients as a proxy, while also taking into account the effects of hosts, vegetation and weather effects. It was predicted that tick abundance would be higher at lower altitudes (i.e. warmer climates) and increase with host abundance. Surveys were conducted on nine hills in Scotland, all of open moorland habitat. Tick abundance was positively associated with deer abundance, but even after taking this into account, there was a strong negative association of ticks with altitude. This was probably a real climate effect, with temperature (and humidity, i.e. saturation deficit) most likely playing an important role. It could be inferred that ticks may become more abundant at higher altitudes in response to climate warming. This has potential implications for pathogen prevalence such as louping ill virus if tick numbers increase at elevations where competent transmission hosts (red grouse Lagopus lagopus scoticus and mountain hares Lepus timidus) occur in higher numbers.

Keywords   Ixodes ricinus  - Louping ill virus - Lyme disease - Deer - Elevation
Lucy Gilbert
Email: l.gilbert@macaulay.ac.uk

http://www.springerlink.com/content/g6357647314303l4/

August 19, 2009

United States Department of Agriculture - Study Shows ARS Device is Highly Effective at Controlling Ticks that Spread Lyme Disease

By Sandy Miller Hays
August 11, 2009

A device called the “4-poster” Deer Treatment Bait Station, developed and patented by scientists with the Agricultural Research Service (ARS), was highly effective at reducing the number of ticks infected with the Lyme disease bacterium in a six-year U.S. Department of Agriculture (USDA) study in five Northeastern states—Maryland, New Jersey, New York, Connecticut and Rhode Island—where the disease is endemic.

In the $2.1 million USDA Northeast Areawide Tick Control Project, investigators noted a 71 percent overall reduction in the number of ticks infected with the Lyme disease bacterium during summer months when most people get the disease. If the 4-poster is used in areas where the disease is endemic, this should translate to a corresponding 71 percent decrease in Lyme disease cases, according to Durland Fish, a professor of epidemiology at Yale School of Public Health and principal investigator for the project. The effectiveness of the 4-poster ranged from 60 to 82 percent among the seven individual 2-square-mile study sites.

The device is a bin that contains corn, with insecticide-laden paint rollers mounted at the bin’s corners. When a deer-the primary carrier of the blacklegged tick, Ixodes scapularis, which carries the Lyme disease bacterium—inserts its muzzle into the bin to feed, it must rub its head, neck and ears against the insecticide-treated rollers. When the deer subsequently grooms itself, the insecticide is spread enough to protect the animal’s entire body.

Developed by ARS scientists at the agency’s Knipling-Bushland U.S. Livestock Insects Research Laboratory in Kerrville, Texas, the 4-poster’s efficacy could be boosted to more than 90 percent by using newer, more effective insecticides that were not available at the start of the USDA study, according to J. Mathews Pound, an entomologist at the Kerrville laboratory and a co-investigator on the study.

The results of the study have been published in a series of 11 papers in the August 2009 issue of the medical journal Vector-borne and Zoonotic Diseases. The articles are available free online.

ARS is the principal intramural scientific research agency of USDA.

http://www.ars.usda.gov/is/pr/2009/090811.2.htm

August 17, 2009

American Medical News - Panel hears conflicting views on Lyme disease treatment

The board of eight physicians and a veterinarian is charged with deciding if one society’s guidelines should be revised.

By Susan J. Landers, AMNews staff. Posted Aug. 17, 2009.
 

Washington — The debate over whether chronic Lyme disease exists and how it should be treated has become increasingly contentious in the past few years, even prompting antitrust charges by one state attorney general over treatment guidelines.

To read full article: CLICK HERE

August 8, 2009

Royal College of Nursing - Lyme disease: A Clear and Present Danger

 Lyme disease: A Clear and Present Danger

Thanks for this article go to WENDY FOX, Chair of Borreliosis and Associated Diseases Awareness UK (BADA-UK), a charity promoting understanding and prevention of Lyme disease.

Before embarking on a trip, travellers obviously should take health protection into account. Many opt for vaccination against diseases, generally associated with travel abroad, but few realise there is an increasing threat within the British Isles, and one that is not vaccine preventable.

Tick-borne disease is increasing in the UK and Ireland. Ticks are the most common arthropod vector of disease and a hard tick (Ixodes species) usually causes infection in the UK. Ticks are most abundant in forested, heathland and moorland areas, but also in suburban parklands. Owing to several factors, including land management and climate changes, parasite numbers have increased and so has their distribution.

Borreliosis (also referred to as Lyme borreliosis or Lyme disease) is most prevalent tick-borne disease. Cases reported via a voluntary surveillance system have trebled in England and Wales since 2001. In Scotland (where the disease is notifiable) they have increased by a factor of eight.

Underestimated

The Health Protection Agency admits that data for reported cases are incomplete because information doesn’t include cases diagnosed and treated on the basis of clinical features, without laboratory tests. They estimate an additional 1,000-2,000 cases each year, with an annual total of approximately 3,000.

Cases in England and Wales are most frequently reported in Exmoor, the New Forest, the South Downs, parts of Wiltshire and Berkshire, Thetford Forest, the Lake District and the North York Moors. However, they have been reported from most counties and the HPA states that any area harbouring ticks may have the potential for borreliosis transmission.

Dr Darrel Ho-Yen, head of the national Lyme Disease Testing Service in Scotland, believes that the known number of proven cases should be multiplied by 10 “to take account of wrongly-diagnosed cases, tests giving false results, sufferers who weren’t tested, people who are infected but not showing symptoms, failures to notify and infected individuals who don’t consult a doctor”.

Diagnostic problems

Borreliosis is caused by a spirochaetal bacterium of the Borrelia genus. Lyme disease is generally associated with Old Lyme, Connecticut, in the United States, acquiring its name after a cluster of cases of Borrelia burgdorferi infection was identified in 1974. Since then, other strains of Borrelia which can have different clinical presentations have been discovered in Europe.

Identifying an infection presents a problem for health care practitioners. There is only one sign specific to Borreliosis - an expanding rash (Erythema Migrans), generally occurring three-to-30 days after a tick bite. This rash doesn’t always occur and can vary in presentation (sometimes misdiagnosed as ringworm, cellulitis or allergic reaction). Of cases reported to the HPA in 2007, only one third had documented Erythema Migrans.

Early symptoms are non-specific and flu-like (tiredness, headaches, arthralgia and myalgia). In the following weeks or months more serious symptoms may appear in untreated patients, affecting the nervous system, joints and the heart or other tissues. Neuroborreliosis (infection of the nervous system) can cause facial palsy, viral-like meningitis, pain, weakness or altered sensation of limbs or trunk.

Lyme arthritis, usually affecting the knee, is more common with disease acquired in North America or some parts of Europe.

Too tiny to detect

Another diagnostic problem occurs when patients don’t recall a tick bite. Of the cases reported to the HPA in 2007, only 43 per cent reported a bite. Because of anaesthetic and anti-inflammatory properties in their saliva, ticks can bite and feed without discovery.

Nymphal ticks (the second stage in a tick’s life-cycle) are the most common cause of infection as they resemble a poppy seed and are seldom seen. Ticks prefer attaching to inaccessible places, like skin folds, armpits, groin, or under hair on the scalp. Body hair will often hide small ticks.

Testing difficulties

A two-tier system is employed in the UK. First, antibody screening tests are performed, followed by immunoblotting (western blotting) of reactive or equivocal samples. Such tests have limitations. Because an antibody response takes several weeks to develop, antibodies may be undetectable in the few weeks after infection. A second sample may then show sero-conversion. Sometimes those with more established infection can be seronegative.

Conversely, people may have antibodies to Borrelia bacteria without having a current infection (regular occupational or recreational exposure to tick bites) and other conditions (for example, glandular fever, syphilis, rheumatoid arthritis) can result in false positive reactions.

A cocktail of infection

Ticks in the UK can carry multiple infections including anaplasmosis, Q-fever, babesiosis and bartonellosis. Clinicians should be aware of the possibility of co-infections, which may cause cases of borreliosis to present atypically and influence treatment choice.

The threat to travellers abroad

Tick-borne diseases are a worldwide concern, with many diseases specific to certain areas. Lyme borreliosis is the most prevalent, being endemic to North America and Eurasia. Tick-borne relapsing fever is also caused by a species of Borrelia bacteria and found primarily in Africa, Spain, Saudi Arabia, Asia and certain areas in the western USA and Canada.

Other risks to travellers include:

•tick-borne encephalitis virus (TBE) - endemic in temperate regions of Europe and Asia
•tularemia (bacterial) - reported from all European countries except Great Britain, Iceland and Portugal. Endemic to the south east, south central and western USA
•Colorado tick fever (virus) - endemic to the western USA
•Crimean-Congo hemorrhagic fever (virus) - endemic in Asia, eastern Europe and the Middle East, but especially common in east and west Africa
•Anaplasmosis (rickettsial) - endemic in the USA and Europe, but recently identified in China
•Rocky Mountain spotted fever (rickettsial) - diagnosed throughout the Americas. Some synonyms in other countries include “tick typhus”, “tobia fever” in Columbia, “São Paulo fever” or “febre maculosa” in Brazil and “fiebre manchada” in Mexico.
•Babesiosis (protozoal) - endemic in many regions of Europe and the USA
•Tick paralysis (toxins) - cases occur in the USA and Canada, Australia and Africa. Cases in Eurasia are sporadic.

Disease prevention


Apart from vaccination (where applicable) the best defence is tick awareness. Using repellents and dressing to deter ticks getting under clothing is good policy. Regular body checks will identify ticks before or soon after they attach, minimising the risk of disease transmission which increases the longer the tick remains attached.

Correct removal of ticks is vitally important and should be performed using a tick-removal tool or fine-tipped tweezers, easily carried (with antiseptic wipes) in pockets or rucksacks. Freezing, burning or smothering a tick with any substances is likely to result in regurgitation of infective fluids. Detailed instructions on tick-removal techniques are available at: www.bada-uk.org (”Defence” section).

When evaluating a patient it is important for health care practitioners to be aware of places people have visited or intend visiting.

http://www.rcn.org.uk/development/communities/specialisms/travel_health/news_stories/lyme_disease_a_clear_and_present_danger

July 27, 2009

PubMed - Perineuritis in acute lyme neuroborreliosis

Muscle Nerve. 2009 Jun;39(6):851- 4.

Elamin M, Alderazi Y, Mullins G, Farrell MA, O’Connell S, Counihan TJ.

Department of Neurology, University College Hospital, Galway, Ireland.

Perineuritis is an unusual cause of direct peripheral nerve injury. We describe the clinicopathologic features of a 56-year-old man with mononeuritis multiplex due to Lyme disease; sural nerve biopsy demonstrated florid perineuritis. Treatment with intravenous ceftriaxone resulted in marked neurologic improvement. This study supports the notion that perineuritis forms part of the pathogenesis in acute Lyme neuroborreliosis. Muscle Nerve, 2009.

PMID: 19441045 [PubMed - in process]

July 26, 2009

Eurosurveillance - Tick-Borne Encephalitis - Still an Emerging Infection in the Region

Contents include:

•Editorial: Tick-Borne Encephalitis – Still an Emerging Infection in the Region
•Epidemiology of Tick-Borne Encephalitis and Lyme Disease in the Republic of Belarus, 1998-2007
•Epidemiological Trends of Tick-Borne Encephalitis in Estonia
•Tick-Borne Pathogens and Spread of Ixodes ricinus in Lithuania
•Tick-Borne Encephalitis in Denmark
•Tick-Borne Encephalitis in Norway
•Tick-Borne Encephalitis in Europe and Beyond – The Epidemiological Situation as of 2007
•Specialist Profile Series: Milda Žygutienė
•Surveillance Data in the EpiNorth Area, 2008

To access PDF file: CLICK HERE

July 23, 2009

PubMed - Imidocarb dipropionate clears persistent Babesia caballi infection with elimination of transmission potential

Antimicrob Agents Chemother. 2009 Jul 20. [Epub ahead of print]

Schwint ON, Ueti MW, Palmer GH, Kappmeyer LS, Hines MT, Cordes RT, Knowles DP, Scoles GA.
Program in Vector-Borne Diseases, Department of Veterinary Microbiology and Pathology, School for Global Animal Heath, Washington State University, Pullman, Washington 99164-7040; Animal Disease Research Unit, U.S. Department of Agriculture, Agricultural Research Service, Pullman, Washington 99164-6630; Department of Veterinary Clinical Sciences, Washington State University, Pullman, Washington 99164-7010; and National Equine Programs, U.S. Department of Agriculture, Animal & Plant Health Inspection Service, Veterinary Services, Riverdale, Maryland 20737-1234.
Antimicrobial treatment of persistent infection to eliminate transmission risk represents a specific challenge requiring compelling evidence of complete pathogen clearance. The limited repertoire of antimicrobial agents targeted at protozoal parasites magnifies this challenge. Using Babesia caballi as both a model and a specific apicomplexan pathogen for which evidence of the elimination of transmission risk is required for international animal movement, we tested whether a high dose regimen of imidocarb dipropionate cleared infection from persistently infected asymptomatic horses and/or eliminated transmission risk. Clearance with elimination of transmission risk was supported by four specific lines of evidence: i) inability to detect parasites by quantitative PCR and nested PCR amplification; ii) conversion from seropositive to seronegative status; iii) inability to transmit infection by direct inoculation of blood into susceptible recipient horses; and iv) inability to transmit infection by ticks acquisition fed on the treated horses and then subsequently transmission fed on susceptible horses. In contrast, untreated horses remained infected and capable of transmitting B. caballi using the same criteria. These findings establish that imidocarb dipropionate treatment clears B. caballi infection with confirmation of lack of transmission risk either by direct blood transfer or a high tick burden. Importantly, the treated horses revert to seronegative status using the international standard for serologic testing and would permit movement between endemic and pathogen-free countries.

PMID: 19620328 [PubMed - as supplied by publisher]

June 29, 2009

Livescience - New Pill Fights Fleas and Ticks in Dog and Cat

By LiveScience Staff, posted: 27 June 2009 10:33 am ET

The first once-a-month pill for controlling both fleas and ticks in dogs and cats is showing promise in tests.

Peter Meinke and colleagues at Merck Research Laboratories note the need for better ways of controlling fleas and ticks, driven in part by increases in pet ownership. Estimates suggest that there were 71 million pet dogs and 81 million pet cats in the United States alone in 2007 — up from 61 million and 70 million in 2001.

Dogs and cats are the most popular pets, unless you count fish, which are thought to be in fewer homes but in greater quantities.

Although many powders, sprays and other topical agents are on the market, many pet owners prefer the convenience of pills. Products given orally can reach more parts of an animal’s body, do not wash off in rain or bath water, and don’t transfer from pets to people.

At least one existing pill fights fleas in pets, but does not appear effective for ticks.

In tests on fleas and ticks in dogs and cats, a single dose of the new pill was 100 percent effective in protecting against both fleas and ticks for a month, the scientists report in Journal of the Medicinal Chemistry.

There were no signs of toxic effects on the animals, according to a statement from the American Chemical Society.

Scientists obtained the flea and tick fighter from a substance first found in a fungus that “has the potential to usher in a new era in the treatment of ecoparasitic [ticks and fleas, for instance] infestations in companion animals,” the scientists write.

http://www.livescience.com/animals/090627-dog-cat-fleas-ticks.html

June 16, 2009

Southern Reporter - Tick tock – time to tuck trousers in your socks

Published Date: 11 June 2009
Ticks can be carriers of Lyme disease and an attach themselves to animals – or humansTICK numbers are on the increase because of climate change, but the Lyme disease they carry is not putting visitors off coming to the Borders, says VisitScotland.

The Tick Alert campaign group says there were 285 cases of Lyme disease – also known as Borreliosis – in Scotland last year, compared with only three recorded cases in 1999.

NHS Borders recorded only two cases of Lyme disease in 2008 and there are none up to March 2009 this year.

And VisitScotland say there is little concern from visitors about the disease in the Borders.

Rising tick numbers will have “little or no impact on tourism” in the region, said a VisitScotland spokesperson.

He said: “There is no evidence to suggest people are not coming to the region for fear of getting Lyme disease from ticks.

“We have checked with our visitor centre staff manager and there have so far been no enquiries of this nature as far as we are aware.”

But while the Borders is not a high-risk area for Lyme disease – unlike the Highlands – there are increasingly high numbers of the blood-sucking insects.

Borreliosis and Associated Diseases Awareness (BADA) UK director Wendy Fox told us: “As a charity we are contacted by more and more people who either have contracted Lyme disease or who are concerned about the number of ticks. People are reporting high densities of ticks where previously there appeared to be few or none at all.”

The charity Tick Alert says numbers of ticks are on the increase worldwide.

A spokeswoman said: “We are getting longer and milder summers and that gives more vegetation for tick hosts such as deer which are increasing in numbers, and hence the number of ticks is also increasing.Climate change is extending the tick season and making them live longer.”

And she said: “The traditional tick areas are changing as they are coming into towns and cities on hosts such as birds and rats.”

Changes to farming practices, too, are allowing the proliferation of ticks.

Ms Fox said: “The growing number of people involved in outdoor activities is almost certainly contributing to the rise in cases of tick-borne disease and as there are no vaccines to defend against them: awareness is the best defence.”

Tick Alert wants people to take tick bite protection as seriously as sun protection and urge people to wear insect repellent and tuck trousers into socks.

And BADA advises ticks should be pulled directly out with tweezers taking care not to squeeze the tick’s body (to avoid the tick’s stomach contents or saliva going into the bite area and possibly infecting the host) and to avoid old wives’ recommendations of using vaseline, paraffin or lit matches.

The most common symptom of Lyme disease is a slowly expanding rash, which spreads about five to 14 days after the tick bite.

Other symptoms can include fever, headache and fatigue.

Most cases can be treated with antibiotics, but if left untreated, infection can spread to joints, the heart, and the nervous system.

And often Lyme disease can be misdiagnosed.

Ms Fox said: “It is recognised that this (the published Lyme disease figures) accounts only for reported cases and there are cases that may go unreported or are left undiagnosed or misdiagnosed.”

More information can be found on www.tickalert.org and www.bada-uk.org

http://www.thesouthernreporter.co.uk/outdoors/Tick-tock–time-to.5350257.jp?articlepage=2

June 9, 2009

Canadian Medical Association - The emergence of Lyme disease in Canada

Nicholas H. Ogden, DPhil, L. Robbin Lindsay, PhD, Muhammad Morshed, PhD, Paul N. Sockett, PhD and Harvey Artsob, PhD

Conclusions and recommendations

The number of known endemic areas of Lyme disease in Canada is increasing because the range of I. scapularis is expanding in the eastern and central provinces. National surveillance must be able to identify this changing pattern. Lyme disease is potentially preventable if people wear appropriate clothing and use N, N-diethyl-meta-toluamide (DEET) repellents. Removal of infected ticks from a person within 24 hours of attachment usually prevents transmission of B. burgdorferi, [23] and early Lyme disease is usually easily treated with antibiotics. [4,24] However, prompt treatment requires recognition of vector ticks and erythema migrans lesions by affected members of the public and prompt diagnosis by clinicians. [24] If Lyme disease is not recognized during the early stages, patients may suffer seriously debilitating disease, which may be more difficult to treat. [4] Therefore, an important function of surveillance is to inform both the public and clinicians about the local risk level and the need for prudent administration of regimens appropriate for prevention and early diagnosis of Lyme disease.

To read full article: CLICK HERE

Newer Posts »

Powered by WordPress